Palisade Capital Management Chief Investment Officer Dan Veru and Senior Vice President of Research Dawn Brock hosted an informative evening with Dr. Kayvon Modjarrad, who leads the U.S. Army's development of a vaccine against COVID-19 and co-leads all of Walter Reed Army Institute of Research’s COVID-19 response efforts. Dr. Modjarrad provided an update on the most recent vaccine efforts and answered questions pertaining to COVID-19 vaccines. Dan and Dawn facilitated the discussion and offered their insights regarding how Palisade Capital views the evolving vaccine landscape as both an investment thesis and as part of 2021’s overall market outlook.
In our latest webinar, Palisade Capital Management Co-Chairman and Chief Investment Officer Dan Veru provides an update following the election and announcements of scientific breakthroughs to combat COVID-19.
In our latest webinar, Palisade Capital Management Co-Chairman and Chief Investment Officer Dan Veru answers questions from participants and shares his current insights as markets continue to digest the ramifications of the COVID-19 pandemic.
We believe 2021 will be another favorable year for convertibles and remain a compelling asset class, especially for those that have re-examined their allocation framework and appetite for risk given the rollercoaster ride of 2020.